EDWIN MARTINEZ: Open Payments
NPI 1245802610 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 25 payments from 16 companies in 2025. Trend: 2023 $268 · 2024 $1,452 · 2025 $607
Food & beverage: $592Education: $15
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 3 | $80 |
| Vantive US Healthcare LLC | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Mallinckrodt Hospital Products Inc. | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Ardelyx, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $25 |
Products named: TARPEYO, Renal - PD, JYNARQUE, TERLIVAZ, Fabhalta, Kerendia, JARDIANCE, IBSRELA.
Industry payments across FL — which companies pay providers there.
